K Pharma (TSE:4896) Payments of Debt: 円0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4896 K Pharma Inc TSE:4896
12 GF Score
Price 円740.00
! 1 Warning Sign
View Full Analysis

What is K Pharma Payments of Debt?

K Pharma TSE:4896 -1.33% 12 Payments of Debt is 円0.00 Mil as of Dec. 2025. GuruFocus rates TSE:4896 with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

K Pharma's Payments of Debt for the three months ended in Dec. 2025 was 円0.00 Mil.

K Pharma's Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2025 was 円0.00 Mil.

K Pharma Payments of Debt Related Terms

K Pharma Payments of Debt Historical Data

* Premium members only.

The historical data trend for K Pharma's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

K Pharma Payments of Debt Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
-30.00 0.00 0.00 0.00 0.00

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4896
12GF Score
K Pharma Inc TSE:4896
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

K Pharma Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of 円0.00 Mil mean?
K Pharma (TSE:4896) has a Payments of Debt of 円0.00 Mil as of Dec. 2025. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on K Pharma and its competitors.
Is K Pharma's Payments of Debt too high?
K Pharma's current Payments of Debt is 円0.00 Mil. Overall, K Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does K Pharma's Payments of Debt compare to VRTX and REGN?
K Pharma's Payments of Debt of 円0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on K Pharma and its competitors. K Pharma's current Payments of Debt is 円0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is K Pharma stock overvalued right now?
K Pharma (TSE:4896) has a current Payments of Debt of 円0.00 Mil. The current Payments of Debt is 円0.00 Mil. K Pharma's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For K Pharma (TSE:4896), the current Payments of Debt is 円0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

K Pharma Business Description

Address 7-7-7 Roppongi, Tri-Seven Roppongi 8th Floor, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales, and marketing of pharmaceutical products and regenerative medicine products. It is involved in the study of iPs cells in regenerative medicine to treat neurological conditions such as cerebral infarction and SCI.
12GF Score

Get the complete analysis for TSE:4896

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円740.00
Price